The parts of the science community that do have a responsibility are the MRC and NIHR. MRC has had ME as a priority since about 2000 and was funding work on muscle metabolism back in the 1980s. I genuinely think that the absence of more biomedical research until now has been the lack of worthwhile studies to do. When I acted as MRC advisor this recent time around the GWAS project was the one thing that looked worthwhile, apart from maybe some actimetry studies.
I think this represents how research funding is organized traditionally in the UK. Academics come up with ideas and put them to the various review boards and then they get funded or not. Its not a proactive approach to identifying areas that are important and doing things to encourage research in these areas - this is what I think is needed.
With DecodeME it was slightly different because this came from a proposal from the CMRC put to the MRCs strategy board who were particularly keen on the GWAS part.
I think the MRC have tried to do a bit for example encouraging the CMRC but they don't seem to have done much to really aim to really build capability in particular research areas where it is lacking.
I went to a talk a couple of years ago where a different research council I don't remember much of what was said but I do remember that they had different funding mechanisms such as the review boards along with special calls and a comment that different research areas used the different mechanisms. I also have memories of initiative so try to bring academics (and industry) together in areas that were considered important and where multidisaplinary research was thought valuable.
So I've long wondered if the MRC could take a more strategic approach to research (and they may do behind the scenes) rather than relying on getting good proposals in areas where people aren't working. Good research proposals will come when good researchers are encouraged to look into ME and where there is good opportunity for funding to make the effort worthwhile (and I don't mean funding bad research).